View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AC41 Publication ID: Fall 2002 
Title: ●Establishment of Prior Notification Requirement for All Imported Food Shipments 
Abstract: This rulemaking is one of a number of actions being taken to improve FDA's ability to respond to threats of bioterrorism. Section 801(m) of the Federal Food, Drug and Cosmetic Act (FFDCA), which was added by section 307 of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, authorizes the Secretary, through FDA, to promulgate final regulations by December 12, 2003. Section 801(m) requires notification to FDA prior to the entry of imported food. The required prior notice would provide the identity of the article of food; the manufacturer; the shipper; the grower, if known at the time of notification; the originating country; the shipping country; and the anticipated port of entry. The regulation would identify the parties responsible for providing the notice and explain the information that the prior notice is required to contain, the method of submission of the notice, and the minimum and maximum period of advance notice required. Section 307 also states that if FDA does not receive prior notice or receives inadequate prior notice, the imported food shall be held at the port of entry until proper notice is provided. 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: Private Sector 
CFR Citation: Not Yet Determined     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: PL 107-188, sec 307   
Legal Deadline:
Action Source Description Date
Final  Statutory    12/12/2003 

Overall Description of Deadline: The Public Health Security and Bioterrorism Preparedness and Response Act of 2002, section 307, directs the Secretary, through FDA, to issue final regulations establishing prior notification requirements for all imported food shipment by December 12, 2003. If FDA fails to issue final regulations by this date, the statute is self-executing on this date, and requires FDA to receive prior notice of not less than 8 hours, nor more than 5 days until final regulations are issued.

Statement of Need: The events of September 11, 2001, highlighted the need to enhance the security of the U.S. food supply. Congress responded by passing the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act), was signed into law on June 12, 2002. The proposed regulations would implement section 307 of the Bioterrorism Act.

Summary of the Legal Basis: Section 307 of the Bioterrorism Act amended the FFDCA by adding section 801(m), which authorizes the Secretary through FDA to establish by regulation requirements for the notification to FDA prior to the entry of imported food. In addition, section 307 of the Bioterrorism Act also amends section 301 of the FFDCA by making the offering of a food for import or the importing of a food without prior notification, as required by the new regulations, a prohibited act.

Alternatives: None, based on clear statutory directive to establish regulations.

Anticipated Costs and Benefits: The prior notification provision is an economically significant regulatory action, mainly because so many shipments are affected. For calendar year 2002, FDA estimates that about 4.7 million human and animal food and dietary supplements line items will be imported into U.S. commerce by airplane, train, vessel, and truck. For those importers who currently do not notify FDA until their actual arrival (or later) at a point of entry, this proposed rule will create a burden as it would require a change in their current methods of operation. Prior notice requirements will also create some additional burdens if FDA requires more imported articles to be held for FDA inspection. FDA costs will include the labor hours, hardware, and software costs for updating the present OASIS system. Technology costs will likely increase further if FDA has to create a stand alone system instead of working through U.S. Customs Service's ACE system to meet the statutory deadlines. FDA costs may also include hiring additional inspectors to certify the receipt of prior notice and clear the food to enter into U.S. commerce, and storing goods, if FDA has to take custody. The provisions will improve substantially FDA's ability to examine imported food for deliberate and accidental contamination. The purpose of the prior notification of imported food shipments is to allow the FDA to determine whether there is any credible evidence or information indicating that an article of food presents a threat of serious adverse health consequences or death to humans or animals, and to receive and review the prior notification, and appropriately respond. It is not possible to directly estimate the benefits of averting a terrorist attack, as we do not know what form an attack might take or the probability of an attack occurring.

Risks: Regulations implementing legislation to protect the health of citizens against bioterrorism would advance the development, organization and enhancement of public health prevention systems and tools. The magnitude of the risks addressed by such systems and tools is at least as great as the other risk reduction efforts within HHS' jurisdiction. These regulations will improve the ability to address credible threats of serious adverse health consequences or death to humans or animals.

Timetable:
Action Date FR Cite
NPRM  12/00/2002    
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: Federal 
Small Entities Affected: Businesses  Federalism: Undetermined 
Included in the Regulatory Plan: Yes 
Agency Contact:
Gerie Voss
Senior Regulatory Counsel
Department of Health and Human Services
Food and Drug Administration
HFS-32, Center for Tobacco Products, 10903 New Hampshire Avenue, Document Control Center, Building 71, Room G335,
Silver Spring, MD 20993
Phone:877 287-1373
Email: ctpregulations@fda.hhs.gov